p53 and p21 expression in bone marrow clots of megaloblastic anemia patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://hdl.handle.net/11449/197171 |
Resumo: | ` The pathogenesis of megaloblastic hemopathies (MH) is centered on the deficiency of vitamin B12 and folic acid with interruption of erythrocyte maturation. This study researched the participation of p53 and p21 in the pathophysiology of the disease. A retrospective study enrolled 95 patients with histopathologic diagnosis by biopsy or bone marrow clot (BMB/BMC), with clinical review and immunohistochemical study in tissue microarray (TMA) for p53 and p21, detailing their marking location. All patients had BMC and only 11 had BMB. The CMO was a differential of this study and it allowed an expanded sample. In the TMA, 63.7% (58/91) of the samples were immunopositive for p53; and 35.2% (31/88) were immunopositive for p21. Nuclear staining, divergent from the literature, was observed in 17.3% (10/58) among those p53+ and in 38.7% (12/31) among those p21+. The pattern of immunostaining showed non-significant differences (P=0.474) regarding morphologic and clinical aspects. The positivity for both may indicate an effective balance between apoptosis and anti-apoptotic action. Excessive inhibition of apoptosis would contribute to high global cellularity, but without functional maturation effectiveness. In conclusion, there is p21 and/or p53 immunoexpression in most cases of this study and there is no clear association between immunoexpression pattern and patient outcome. Unlike the literature, we also found a percentage of nuclear immunostaining, but the finding was not statistically significant. Combination of p21 and p53 results created different possibilities of pathologic interpretation for MH, reinforcing the importance of studies similar to this one. |
id |
UNSP_c820ee2f19affdba50940b2e74f8e381 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/197171 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
p53 and p21 expression in bone marrow clots of megaloblastic anemia patientsAnemiamegaloblastictumor suppressor protein p53oncogene protein p21(ras)bone marrowbone marrow cellsimmunohistochemistry` The pathogenesis of megaloblastic hemopathies (MH) is centered on the deficiency of vitamin B12 and folic acid with interruption of erythrocyte maturation. This study researched the participation of p53 and p21 in the pathophysiology of the disease. A retrospective study enrolled 95 patients with histopathologic diagnosis by biopsy or bone marrow clot (BMB/BMC), with clinical review and immunohistochemical study in tissue microarray (TMA) for p53 and p21, detailing their marking location. All patients had BMC and only 11 had BMB. The CMO was a differential of this study and it allowed an expanded sample. In the TMA, 63.7% (58/91) of the samples were immunopositive for p53; and 35.2% (31/88) were immunopositive for p21. Nuclear staining, divergent from the literature, was observed in 17.3% (10/58) among those p53+ and in 38.7% (12/31) among those p21+. The pattern of immunostaining showed non-significant differences (P=0.474) regarding morphologic and clinical aspects. The positivity for both may indicate an effective balance between apoptosis and anti-apoptotic action. Excessive inhibition of apoptosis would contribute to high global cellularity, but without functional maturation effectiveness. In conclusion, there is p21 and/or p53 immunoexpression in most cases of this study and there is no clear association between immunoexpression pattern and patient outcome. Unlike the literature, we also found a percentage of nuclear immunostaining, but the finding was not statistically significant. Combination of p21 and p53 results created different possibilities of pathologic interpretation for MH, reinforcing the importance of studies similar to this one.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Sao Paulo State Univ FMB UNESP, Botucatu Med Sch, Botucatu, SP, BrazilSao Paulo State Univ FMB UNESP, Botucatu Med Sch, Salomao & Zoppi DASA, Botucatu, SP, BrazilSao Paulo State Univ FMB UNESP, Botucatu Med Sch, Dept Pathol, Botucatu, SP, BrazilSao Paulo State Univ FMB UNESP, Botucatu Med Sch, Dept Clin Med, Botucatu, SP, BrazilSao Paulo State Univ FMB UNESP, Botucatu Med Sch, Dept Pathol, 266 Bairro Jardim Oriental, BR-04321120 Sao Paulo, SP, BrazilHosp Sao Luiz D, Dept Anat Pathol, 266 Bairro Jardim Oriental, BR-04321120 Sao Paulo, SP, BrazilSao Paulo State Univ FMB UNESP, Botucatu Med Sch, Botucatu, SP, BrazilSao Paulo State Univ FMB UNESP, Botucatu Med Sch, Salomao & Zoppi DASA, Botucatu, SP, BrazilSao Paulo State Univ FMB UNESP, Botucatu Med Sch, Dept Pathol, Botucatu, SP, BrazilSao Paulo State Univ FMB UNESP, Botucatu Med Sch, Dept Clin Med, Botucatu, SP, BrazilSao Paulo State Univ FMB UNESP, Botucatu Med Sch, Dept Pathol, 266 Bairro Jardim Oriental, BR-04321120 Sao Paulo, SP, BrazilFAPESP: 2016/19725-3E-century Publishing CorpUniversidade Estadual Paulista (Unesp)Hosp Sao Luiz DKwan, Denis Nicolas [UNESP]Queiroz Rocha, Julia Thalita [UNESP]Niero-Melo, Ligia [UNESP]Custodio Domingues, Maria Aparecida [UNESP]Oliveira, Cristiano Claudino [UNESP]2020-12-10T20:08:26Z2020-12-10T20:08:26Z2020-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1829-1833International Journal Of Clinical And Experimental Pathology. Madison: E-century Publishing Corp, v. 13, n. 7, p. 1829-1833, 2020.1936-2625http://hdl.handle.net/11449/197171WOS:000558744300005Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengInternational Journal Of Clinical And Experimental Pathologyinfo:eu-repo/semantics/openAccess2024-09-03T13:17:57Zoai:repositorio.unesp.br:11449/197171Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-03T13:17:57Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
p53 and p21 expression in bone marrow clots of megaloblastic anemia patients |
title |
p53 and p21 expression in bone marrow clots of megaloblastic anemia patients |
spellingShingle |
p53 and p21 expression in bone marrow clots of megaloblastic anemia patients Kwan, Denis Nicolas [UNESP] Anemia megaloblastic tumor suppressor protein p53 oncogene protein p21(ras) bone marrow bone marrow cells immunohistochemistry |
title_short |
p53 and p21 expression in bone marrow clots of megaloblastic anemia patients |
title_full |
p53 and p21 expression in bone marrow clots of megaloblastic anemia patients |
title_fullStr |
p53 and p21 expression in bone marrow clots of megaloblastic anemia patients |
title_full_unstemmed |
p53 and p21 expression in bone marrow clots of megaloblastic anemia patients |
title_sort |
p53 and p21 expression in bone marrow clots of megaloblastic anemia patients |
author |
Kwan, Denis Nicolas [UNESP] |
author_facet |
Kwan, Denis Nicolas [UNESP] Queiroz Rocha, Julia Thalita [UNESP] Niero-Melo, Ligia [UNESP] Custodio Domingues, Maria Aparecida [UNESP] Oliveira, Cristiano Claudino [UNESP] |
author_role |
author |
author2 |
Queiroz Rocha, Julia Thalita [UNESP] Niero-Melo, Ligia [UNESP] Custodio Domingues, Maria Aparecida [UNESP] Oliveira, Cristiano Claudino [UNESP] |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) Hosp Sao Luiz D |
dc.contributor.author.fl_str_mv |
Kwan, Denis Nicolas [UNESP] Queiroz Rocha, Julia Thalita [UNESP] Niero-Melo, Ligia [UNESP] Custodio Domingues, Maria Aparecida [UNESP] Oliveira, Cristiano Claudino [UNESP] |
dc.subject.por.fl_str_mv |
Anemia megaloblastic tumor suppressor protein p53 oncogene protein p21(ras) bone marrow bone marrow cells immunohistochemistry |
topic |
Anemia megaloblastic tumor suppressor protein p53 oncogene protein p21(ras) bone marrow bone marrow cells immunohistochemistry |
description |
` The pathogenesis of megaloblastic hemopathies (MH) is centered on the deficiency of vitamin B12 and folic acid with interruption of erythrocyte maturation. This study researched the participation of p53 and p21 in the pathophysiology of the disease. A retrospective study enrolled 95 patients with histopathologic diagnosis by biopsy or bone marrow clot (BMB/BMC), with clinical review and immunohistochemical study in tissue microarray (TMA) for p53 and p21, detailing their marking location. All patients had BMC and only 11 had BMB. The CMO was a differential of this study and it allowed an expanded sample. In the TMA, 63.7% (58/91) of the samples were immunopositive for p53; and 35.2% (31/88) were immunopositive for p21. Nuclear staining, divergent from the literature, was observed in 17.3% (10/58) among those p53+ and in 38.7% (12/31) among those p21+. The pattern of immunostaining showed non-significant differences (P=0.474) regarding morphologic and clinical aspects. The positivity for both may indicate an effective balance between apoptosis and anti-apoptotic action. Excessive inhibition of apoptosis would contribute to high global cellularity, but without functional maturation effectiveness. In conclusion, there is p21 and/or p53 immunoexpression in most cases of this study and there is no clear association between immunoexpression pattern and patient outcome. Unlike the literature, we also found a percentage of nuclear immunostaining, but the finding was not statistically significant. Combination of p21 and p53 results created different possibilities of pathologic interpretation for MH, reinforcing the importance of studies similar to this one. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-10T20:08:26Z 2020-12-10T20:08:26Z 2020-01-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
International Journal Of Clinical And Experimental Pathology. Madison: E-century Publishing Corp, v. 13, n. 7, p. 1829-1833, 2020. 1936-2625 http://hdl.handle.net/11449/197171 WOS:000558744300005 |
identifier_str_mv |
International Journal Of Clinical And Experimental Pathology. Madison: E-century Publishing Corp, v. 13, n. 7, p. 1829-1833, 2020. 1936-2625 WOS:000558744300005 |
url |
http://hdl.handle.net/11449/197171 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
International Journal Of Clinical And Experimental Pathology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
1829-1833 |
dc.publisher.none.fl_str_mv |
E-century Publishing Corp |
publisher.none.fl_str_mv |
E-century Publishing Corp |
dc.source.none.fl_str_mv |
Web of Science reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1810021401298468864 |